Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.
about
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyTryptophan degradation in women with breast cancer: a pilot studyTumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.How interacting pathways are regulated by miRNAs in breast cancer subtypes.Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer.Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.Interferon-γ produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells.Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switchingThe tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side ChainT-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications.Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity.Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.
P2860
Q27002646-119DDB94-53BB-4616-9B97-225DD10A277FQ33912950-5A36B727-965C-4851-A726-84D7C7C1A68AQ35974293-5491ABC8-CF79-425B-BD7C-1165236DAE0AQ36276533-7D8A3AAA-B17A-49F8-8E2B-68EF9B31FB4DQ37301247-CFD42743-062D-4AD9-AD91-9E2ED0863843Q37329058-A01B6006-BCF6-4C58-A5B6-5084E18B487EQ37522460-A640E542-EBB1-4A42-937C-6B4A296445F1Q37939411-B9B5A7CE-EFFB-4C4D-9A5B-5D0C92221101Q38112578-0E8D9192-F358-4735-8251-F357EC03F217Q38383263-06314661-7936-473E-A707-B0E2761692A9Q38801839-0953E5E4-C644-4587-AC34-C5AAD93D4524Q39076405-24EDEE97-C4AA-4881-867D-DAC9FAE472A3Q39616253-4CF09ADE-899E-46B4-9E4B-D0BC2BDB4E52Q41577994-564EC7B8-0DF4-4C8E-A5D9-C6D9197B1440Q41981559-14A2F74A-E44D-418F-820E-1C105E7562AAQ42408344-C82A8D77-1199-4FE7-AC13-41BCBA96FC4EQ45865862-3294BFE9-90E8-4791-9EB2-49820DDF6DB5Q51597260-96788AA8-1E9A-498C-9FD4-A7D8BACB9BD6
P2860
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@en
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@nl
type
label
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@en
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@nl
prefLabel
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@en
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@nl
P2093
P50
P1476
Critical role of indoleamine 2 ...... tments with targeted IFNgamma.
@en
P2093
Angelina Sacchi
Anna Maria Gasparri
Catia Traversari
Gian-Paolo Rizzardi
P304
P356
10.1158/1535-7163.MCT-08-0538
P577
2008-12-01T00:00:00Z